Industry Trends

'OpenAI vs Google': ChatGPT traffic down 21% over six weeks as Gemini stays flat, says Similarweb

ChatGPT, the flagship generative AI product from OpenAI, is showing signs of slowing momentum as Google’s Gemini continues to narrow the gap, according to fresh traffic and market-share data from Similarweb. Data reviewed by Similarweb shows that ChatGPT’s average daily visits have fallen sharply over the past six weeks. Traffic declined by about 22%, with the seven-day average dropping from roughly 203 million visits to around 158 million by early January. Over the same period, Google’s Gemini held steady, recording about 55-60 million daily visits. The shift has translated into a measurable change in market share. ChatGPT’s share of the global generative AI market stood at about 64.5% as of January 2, 2026, down from around 68% in December 2025 and sharply lower than its 86% share a year ago in January 2025. Gemini, meanwhile, has expanded its footprint significantly, growing from 5.7% a year ago to approximately 21.5% now. Other platforms remain smaller but are gaining traction. ...

Industry Trends

Investors chose Gold ETFs over Equities in December 2025

Net inflows into gold exchange traded funds tripled to a record high of ₹1,16,467 crore in Dec. 2025 from the month earlier,according to AMFI data; surge due to ‘sustained demand for gold-backed products amid elevated macro uncertainty

Industry Trends

Phoenix Mills Q3 Update: Retail consumption up 20%, office occupancy at 77%

Phoenix Mills reported 20% YoY growth in Q3 FY26 retail consumption to ₹4,787 crore, improved office occupancy to 77% with 1.20 msft leased in 9M FY26, steady hospitality performance with RevPAR growth at The St. Regis Mumbai, and higher residential sales of ₹140 crore in the quarter.

Industry Trends

Aurobindo Pharma arm’s biosimilar gets Health Canada NOC

A notice of compliance from Health Canada is issued to a drug manufacturer after a successful review, confirming the product meets regulatory standards for safety, efficacy and quality under the Food and Drug Regulations